Resazurin Drug Susceptibility

The assay signal depends on cellular metabolism rather than merely the presence of cells. Living, metabolically active microorganisms reduce resazurin, producing pink, fluorescent resorufin. Consequently, stronger conversion indicates greater metabolic activity, whereas reduced conversion under an antimicrobial condition indicates loss or suppression of viable cellular activity. This biochemical link makes the readout useful for drug-response testing.

Resazurin drug susceptibility can be read in two ways: visible color change or fluorescence. Color provides a straightforward visual comparison, while fluorescence offers another way to detect the resorufin product across drug concentrations. Using either signal, investigators can compare cellular viability between treated conditions and assess how consistently an antimicrobial suppresses microbial activity.

Testing a range of antimicrobial concentrations reveals how microbial viability changes as drug exposure increases. This concentration-based response helps investigators estimate inhibitory activity rather than recording only whether a compound has an effect. Comparing response patterns can also support classification of organisms as more susceptible or more resistant within the tested conditions.

Within broth microdilution and related screening workflows, researchers evaluate microorganisms across antimicrobial concentrations and then assess the resulting resazurin conversion. The color or fluorescence readout provides a practical basis for comparing growth-related metabolic activity between conditions. This workflow supports systematic evaluation of inhibitory responses while retaining a relatively simple measurement strategy.

By applying the same colorimetric or fluorescent readout across candidate compounds, investigators can compare how strongly each treatment suppresses microbial metabolic activity. Differences in signal across drug concentrations provide evidence for relative inhibitory activity and help identify candidates that produce stronger responses against the organisms under study. The method therefore supports early antimicrobial screening.

In immunology and infection research, the assay links antimicrobial exposure with measurable changes in microorganism viability, supporting studies of host-pathogen biology and treatment response. Researchers can use it to examine susceptible or resistant organisms, evaluate therapeutic candidates, and rapidly assess treatment efficacy. Its readout is especially useful when experiments require comparisons across multiple drug conditions.